Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of the American Society of Nephrology (JASN)
Published October 24, 2026
Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Randomized C...
October 25, 2026
Medspoke
Medspoke
Kidney International Reports
Published September 1, 2026
00:00
--:--
Renal Blood Flow as Marker for Disease Progression in ADPKD.
October 25, 2026
Share
Renal Blood Flow as Marker for Disease Progression in ADPKD.
https://www.medspoke.co/channel_journal?id=685&tap_id=16277
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Kidney International Reports
Published September 7, 2026
Belimumab With Rituximab for the Treatment of Primary Membranous Nephropathy.
October 25, 2026
Why are you reporting this TALK?
